The bill establishes a new section in Florida law, specifically s. 627.42398, which sets forth cost-sharing requirements for diabetes management. It defines key terms related to diabetes care, including "cost-sharing requirement," "diabetes device," and "diabetic ketoacidosis device." The legislation prohibits health insurance policies from imposing a cost-sharing requirement that exceeds $35 for a 30-day supply of insulin, regardless of the type or quantity prescribed, and $100 for a 30-day supply of any diabetes device or diabetic ketoacidosis device.

This new regulation will apply to all health insurance policies delivered, issued, renewed, or amended on or after January 1, 2027, and encompasses various types of health insurers, including group and health maintenance organizations. The act is set to take effect on July 1, 2026.